Jul 10, 2026Aging BiomarkersBlood Biomarkers May Improve Cognitive-Decline Trial EnrollmentGFAP, NfL, p-tau, and amyloid blood tests may help enroll higher-risk cognitive-decline trial participants, but they cannot yet predict your future.gfapnflphosphorylated tauamyloid ratiosRead article →